- •Peripartum HIV-RNA is the strongest factor influencing vertical transmission of HIV.
- •When HIV-RNA is <50 copies/mL, ART discontinuation is the strongest risk factor.
- •Intrapartum ZDV has no effect on transmission in women with HIV RNA <50 copies/mL.
- •The administration of unnecessary zidovudine may be perceived as a stigma.
- •Study of the U=U concept in mother-child couple could help fight stigma.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Reduction of maternal-infant transmission of Human Immunodeficiency Virus Type 1 with Zidovudine treatment.N Engl J Med. 1994; 331: 1173-1180https://doi.org/10.1056/NEJM199411033311801
EACS European Aids Clinical Society. Guidelines. Version 11.0. October 2021. https://www.eacsociety.org/media/final2021eacsguidelinesv11.0_oct2021.pdf
Panel on treatment of pregnant women with HIV infection and prevention of perinatal transmission. Recommendations for the use of antiretroviral drugs during pregnancy and interventions to reduce perinatal HIV transmission in the United States.:478. https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/Perinatal_GL.pdf
- HIV and pregnancy: 2013 guidelines from the French expert working group.J Gynecol Obstet Biol Reprod. 2014; 43: 534-548https://doi.org/10.1016/j.jgyn.2014.01.006
British HIV Association (BHIVA). British HIV Association guidelines for the management of HIV in pregnancy and postpartum 2018 (2020 third interim update). Published online 2020. https://www.bhiva.org/file/5f1aab1ab9aba/BHIVA-Pregnancy-guidelines-2020-3rd-interim-update.pdf
Società Italiana di Malattie Infettive (SIMIT). Linee Guida Italiane sull'utilizzo della Terapia Antiretrovirale e la gestione diagnostico-clinic elle persone con infezione da HIV-1. Published online 2017. http://www.salute.gov.it/imgs/C_17_pubblicazioni_2696_allegato.pdf
- Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?.Clin Infect Dis. 2013; 57: 903-914https://doi.org/10.1093/cid/cit374
- Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy.JAMA. 2016; 316: 171https://doi.org/10.1001/jama.2016.5148
- Il Registro Italiano per l'Infezione da HIV in pediatria. L'epidemiologia dell'infezione da HIV nel bambino e nell'adolescente in Italia.JHA. 2017; : 3https://doi.org/10.19198/JHA31433
- Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?.Clin Infect Dis. 2009; 48: 1310-1317https://doi.org/10.1086/597774
- Missed opportunities to prevent mother-to-child transmission of HIV in Italy.HIV Med. 2019; 20: 330-336https://doi.org/10.1111/hiv.12728
- British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review): BHIVA guidelines for the management of HIV infection in pregnant women 2012 (2014 update).HIV Med. 2014; 15: 1-77https://doi.org/10.1111/hiv.12185
- Evidence-based renewal of the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons.New Microbiol. 2018; 41: 247-255
- Duration of membrane rupture and risk of perinatal transmission of HIV-1 in the era of combination antiretroviral therapy.Am J Obstet Gynecol. 2012; 207 (482.e1-5)https://doi.org/10.1016/j.ajog.2012.10.862
- Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants.AIDS. 2013; 27: 991-1000https://doi.org/10.1097/QAD.0b013e32835cffb1
- Zidovudine use in pregnancy and congenital malformations.AIDS. 2017; 31: 1733-1743https://doi.org/10.1097/QAD.0000000000001549
- Pregnancy and neonatal outcomes among a cohort of HIV-infected women in a large Italian teaching hospital: a 30-year retrospective study.Epidemio Infect. 2017; (Published online): 1-12https://doi.org/10.1017/S095026881700053X